Try The China Perspective Free
| HOME PAGE | RESOURCES | MOST POPULAR | EDITORS PICKS | EDITORS BLOG | Free 7-Day Trial | Login |
Try The China Perspective Free |
Pharmaceuticals |
|
| Thursday, January 08, 2009 18:46:30 |
Zhejiang drugmaker acquires parent's assets
Zhejiang Hisun Pharmaceutical (600267.SH) said Monday that it will purchase its parent’s development and research center for US$12.71 million (RMB86.79 million) and its ...
You are currently reading 26 words of 79 total words in this article.
To continue reading this article, you must be a subscriber. Log in now.
NOT A SUBSCRIBER? START YOUR 7-DAY FREE TRIAL NOW.
|
Today’s Daily Briefs E-Mail
Sign up for a roundup of the day’s top stories, sent every day.
 |
|
|
|
 |
Archive | About us | Affiliates | Privacy Policy | Contact us Partners | China News | Subscriber Agreement & Terms of Use
China Business News @ The China Perspective
|
|
bookmark
digg